Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical SofPulse
medical device investing Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device
medical device investing Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics™ Reduced Infarct Size
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
